A recent meta-analysiscomparing P2Y12 inhibitor monotherapy with prolonged (≥12 months)DAPT (including aspirin) after PCI found that the P2Y12 monotherapy grouphad a lower risk of major bleeding and no increased risk of stent thrombosis,all-cause mortality, or stroke [69]. Here, P2RY12 is linked to stroke disorder.